Use of the pup as the statistical unit in developmental neurotoxicity studies: Overlooked model or poor research design?

Toxicological Sciences

Volumn 103, Issue 2, 2008, Pages 409-410

  Hardy, Marcia ^a   Stedeford, Todd ^a  

^a Albemarle Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,2' 4,4', 5 PENTABROMODIPHENYL ETHER; FLAME RETARDANT; METHYLMERCURY;

BEHAVIOR DISORDER; CLINICAL RESEARCH; DEVELOPMENTAL DISORDER; DISEASE MODEL; HABITUATION; LEARNING DISORDER; LETTER; MEMORY DISORDER; METHODOLOGY; NEUROTOXICITY; NONHUMAN; PEER REVIEW; PUBLICATION; STATISTICAL ANALYSIS;

ANIMALS; ANIMALS, NEWBORN; DATA INTERPRETATION, STATISTICAL; MICE; NERVOUS SYSTEM; NEUROTOXICITY SYNDROMES; RESEARCH DESIGN; TOXICITY TESTS;

EID: 43349102568     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfn036     Document Type: Letter

References (13)

1. European Chemicals Bureau. (2062). European Union risk assessment report bis(pentabromophenyl) ether. 17, 1-292.
2. EPA. (2000). Benchmark dose technical guidance document, EPA/630/R-00/ 001, pp. 1-87.
3. Eriksson, P., and Viberg, H. (2005). Chapter 5. Tiered testing in mammals - The neonatal animal model. In Science for a Safe Chemical Environment (S. Ove Hansson and C. Rudén, Eds.), pp. 103-133. US-AB Universitetsservice AB, Stockholm, Sweden.
4. Eriksson, P., von Rosen, D., Viberg, H., and Fredriksson, A. (2005). Developmental toxicology in the neonatal mouse: The use of randomly selected individuals as statistical unit compared to the litter in mice neonatally exposed to PBDE 99. The Toxicologist 1074, (Abstract). pp. 219-220.
5. Fischer, C., Fredriksson, A., and Eriksson, P. (2008). Co-exposure of neonatal mice to a flame retardant PBDE 99 (2,2′,4,4′,5-pentabromodiphenyl ether) and methylmercury enhances developmental neurotoxic defects. Toxicol. Sci. 101, 275- 285; First published on November 2, 2007
6. Fredriksson, A. (1994). MPTP-Induced Behavioral, Deficits in Mice: Validity and Utility of a Model of Parkinsonism. Uppsala University, Uppsala.
7. Grainger, D. W. (2007). Peer review as professional responsibility: A quality control system only as good as the participants. Biomaterials 28, 5199-5203.
8. Holson, R. R., and Pearce, B. (1992). Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicol. Teratol. 14, 221-228.
9. Holson, R. R., Freshwater, L., Maurissen, J. P. J., Moser, V. C., and Phang W. (2007). Statistical issues and techniques appropriate for developmental neurotoxicity testing. A report from the ILSI Risk Science Institute Expert Panel on neurodevelopmental endpoints. Neurotoxicol. Teratol. doi: 10.1016/j.ntt.2007.06/001
10. IRIS. (2006a). Toxicological review of pentabromodiphenyl ether (BDE-99) (CASRN 60348-60-9) [external review draft]. Available at: http://oaspub.epa.gov/eims/eimscomm.getfile?p_download_id=459969. Access date February 5, 2008.
11. IRIS. (2006b). Toxicological review of decabromodiphenyl ether (BDE 209) (CASRN 1163-19-5) [external review draft]. Available at: http://oaspub.epa.gov/eims/eimscomm.getfile?p_download_id=459974
12. MSL. (2004). Maine State Legislature, PL 2003, c. 629, An Act to reduce the Contamination of Breast Miik and the Environment from the Release of Brominated Chemicals in Consumer Products, effective July 30, 2004.
13. OECD. (2007). Developmental Neurotoxicity Study, OECD Guideline for the Testing of Chemicals #426, pp. 1-26.